Open main menu
EN
新闻
上一篇
返回
下一篇
MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity
2022-12-23